The San Diego-based continuous glucose monitor (CGM) maker announced plans to invest $325 million in Athenry last May. Breaking ground on the facility marks the first steps toward bringing more than 1,000 jobs to the area. The company expects the factory to be completely built by the second half of 2025.
Dexcom EVP of Global Operations, Barry Regan, explained what attracted the company to the growing medtech hub last year. The company says its investment represents one of the biggest single private sector investments ever in the west of Ireland. Dexcom is the latest CGM maker to break ground in Ireland, as Abbott began construction on a Kilkenny FreeStyle Libre manufacturing plant last April.
According to a news release, Dexcom plans for its first manufacturing facility in Europe to ensure the flow of products in EMEA. The company sees the potential to lower the cost of goods and improve sustainability by decreasing delivery time in transit. It expects the new facility to produce millions of CGM sensors each year.
Get the full story at our sister site, Drug Delivery Business News.
